[TNGX] QoQ Quarter Result on 30-Sep-2022 [#Q3]

Stock
[TNGX] Tango Therapeutics, Inc.
Announcement Date
10-Nov-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- -13.35%
YoY- -43.83%
Quarter Report
TNGX's Result
TNGX's Financial Summary
View:
Show?
Quarter Result
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Revenue 14,598 5,766 6,411 6,920 5,771 5,758 5,716 87.16%
PBT -20,646 -28,008 -29,009 -29,050 -24,855 -25,208 -21,869 -3.77%
Tax 64 -2,278 51 -873 3 -171 177 -49.34%
NP -20,710 -25,730 -29,060 -28,177 -24,858 -25,037 -22,046 -4.09%
Tax Rate - - - - - - - -
Total Cost 35,308 31,496 35,471 35,097 30,629 30,795 27,762 17.43%
Ratio Analysis
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
NP Margin -141.87 -446.24 -453.28 -407.18 -430.74 -434.82 -385.69 -48.75%
Per Share
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
EPS -0.23 -0.29 -0.33 -0.32 -0.28 -0.29 -0.25 -5.42%
EPS Diluted -0.23 -0.29 -0.33 -0.32 -0.28 -0.29 -0.25 -5.42%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.